{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:28:42Z","timestamp":1790252922622,"version":"4.1.0"},"reference-count":37,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Chronic hepatitis C virus (HCV) infections are causally linked with metabolic comorbidities such as insulin resistance, hepatic steatosis, and dyslipidemia. However, the clinical impact of HCV eradication achieved by direct-acting antivirals (DAAs) on glucose and lipid homeostasis is still controversial. The study aimed to prospectively investigate whether antiviral therapy of HCV with DAAs alters glucose and lipid parameters. Methods: 50 patients with chronic HCV who were treated with DAAs were screened, and 49 were enrolled in the study. Biochemical and virological data, as well as noninvasive liver fibrosis parameters, were prospectively collected at baseline, at the end of treatment (EOT) and 12 and 24 weeks post-treatment. Results: 45 of 46 patients achieved sustained virologic response (SVR). The prevalence of insulin resistance (HOMA-IR) after HCV clearance was significantly lower, compared to baseline (5.3 \u00b1 6.1 to 2.5 \u00b1 1.9, p &lt; 0.001), which is primarily attributable to a significant decrease of fasting insulin levels (18.9 \u00b1 17.3 to 11.7 \u00b1 8.7; p = 0.002). In contrast to that, HCV eradication resulted in a significant increase in cholesterol levels (total cholesterol, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein (HDL-C) levels) and Controlled Attenuated Score (CAP), although BMI did not significantly change over time (p = 0.95). Moreover, HOMA-IR correlated significantly with noninvasive liver fibrosis measurements at baseline und during follow-up (TE: r = 0.45; p = 0.003, pSWE: r = 0.35; p = 0.02, APRI: r = 0.44; p = 0.003, FIB-4: r = 0.41; p &lt; 0.001). Conclusion: Viral eradication following DAA therapy may have beneficial effects on glucose homeostasis, whereas lipid profile seems to be worsened.<\/jats:p>","DOI":"10.3390\/jcm9092702","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T09:21:51Z","timestamp":1598001711000},"page":"2702","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis"],"prefix":"10.3390","volume":"9","author":[{"given":"Christiana","family":"Graf","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Welzel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Bogdanou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Vermehren","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Beckel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Bojunga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireen","family":"Friedrich-Rust","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Dietz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8627-6088","authenticated-orcid":false,"given":"Alica","family":"Kubesch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Mondorf","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Fischer","sequence":"additional","affiliation":[{"name":"Infektiologikum, Center for Infectious Diseases, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lutz","sequence":"additional","affiliation":[{"name":"Infektiologikum, Center for Infectious Diseases, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Stoffers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Institute of Biostatistics and Mathematical Modeling, Goethe University Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Poynard","sequence":"additional","affiliation":[{"name":"BioPredictive, 75007 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zeuzem","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Dultz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Mihm","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"key":"ref_1","unstructured":"WHO (2020, April 20). The Global Burden of Viral Hepatitis: Better Estimates to Guide Hepatitis Elimination Efforts. Available online: http:\/\/www.who.int\/mediacentre\/commentaries\/better-estimates-hepatitis\/en\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.27424","article-title":"Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients","volume":"61","author":"Meissner","year":"2015","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0168-8278(05)80631-2","article-title":"Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population","volume":"21","author":"Allison","year":"1994","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.510290235","article-title":"Association of diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Mason","year":"1999","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1478-3231.2007.01630.x","article-title":"Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: Comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients","volume":"28","author":"Imazeki","year":"2008","journal-title":"Liver Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00592-011-0293-x","article-title":"HBV and HCV infection in type 2 diabetes mellitus: A survey in three diabetes units in different Italian areas","volume":"48","author":"Soverini","year":"2011","journal-title":"Acta Diabetol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.22269","article-title":"Hepatitis C virus infection: Molecular pathways to metabolic syndrome","volume":"47","author":"Sheikh","year":"2008","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)63408-6","article-title":"Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3","volume":"165","author":"Kawaguchi","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/jvh.13215","article-title":"Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance","volume":"27","author":"Russo","year":"2019","journal-title":"J. Viral Hepat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/jvh.12887","article-title":"Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States","volume":"25","author":"Li","year":"2018","journal-title":"J. Viral Hepat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/liv.13669","article-title":"Hepatitis C virus eradication by direct antiviral agents improves glucose tolerance and reduces post-load insulin resistance in nondiabetic patients with genotype 1","volume":"38","author":"Salomone","year":"2018","journal-title":"Liver Int."},{"key":"ref_15","unstructured":"(2020, June 01). Viral Clearance Is Associated With Improved Insulin Resistance in Genotype 1 Chronic Hepatitis C but Not Genotype 2\/3, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/21873466\/?from_single_result=10.1136%2Fgut.2010.236158."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5604\/16652681.1231581","article-title":"Effect of treatment with direct acting antiviral on glycemic control in patients with diabetes mellitus and chronic hepatitis C","volume":"16","author":"Stine","year":"2017","journal-title":"Ann. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/infdis\/jix517","article-title":"no improvement in hemoglobin A1c following hepatitis C viral clearance in patients with and without HIV","volume":"217","author":"Chaudhury","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_18","unstructured":"(2020, June 01). Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but Not Glucose Parameters, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/30884773\/."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.gastro.2010.08.055","article-title":"Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C","volume":"140","author":"Rao","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1440-1746.2012.07267.x","article-title":"Combination of fluvastatin with pegylated interferon\/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b","volume":"28","author":"Atsukawa","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/hep.23787","article-title":"Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy","volume":"52","author":"Harrison","year":"2010","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"European Association for the Study of the Liver (EASL) recommendations on treatment of hepatitis C 2018","volume":"69","author":"Pawlotsky","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"Moucari","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study","volume":"357","author":"Ratziu","year":"2001","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1148\/radiol.2523081928","article-title":"Liver fibrosis in viral hepatitis: Noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography","volume":"252","author":"Wunder","year":"2009","journal-title":"Radiology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1478-3231.2008.01802.x","article-title":"Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B","volume":"29","author":"Marcellin","year":"2009","journal-title":"Liver Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/j.1572-0241.2003.08728.x","article-title":"Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association","volume":"98","author":"Knobler","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4254\/wjh.v8.i2.131","article-title":"Hepatitis C and insulin action: An intimate relationship","volume":"8","author":"Knobler","year":"2016","journal-title":"World J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/jgh.14067","article-title":"Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients","volume":"33","author":"Adinolfi","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/01.mcg.0000225593.93577.64","article-title":"A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C","volume":"41","author":"Alsatie","year":"2007","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/gut.2004.050302","article-title":"Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C","volume":"54","author":"Fartoux","year":"2005","journal-title":"Gut"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.27212","article-title":"Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort study","volume":"60","author":"Huang","year":"2014","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/gast.2003.50018","article-title":"Progression of fibrosis in chronic hepatitis C","volume":"124","author":"Ghany","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2893.2005.00677.x","article-title":"Diabetes mellitus in chronic hepatitis B and C: Prevalence and potential association with the extent of liver fibrosis","volume":"13","author":"Papatheodoridis","year":"2006","journal-title":"J. Viral Hepat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor","volume":"96","author":"Agnello","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/9\/2702\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:04:31Z","timestamp":1760177071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/9\/2702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["jcm9092702"],"URL":"https:\/\/doi.org\/10.3390\/jcm9092702","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,21]]}}}